What are the opening hours?

Monday 8:30am - 4pm Tuesday 8:30am - 4pm Wednesday 8:30am - 4pm Thursday 8:30am - 4pm Friday 8:30am - 4pm

Dr. Todd Lanman - Lanman Spinal Neurosurgery

Home
United States
Beverly Hills, CA
Dr. Todd Lanman - Lanman Spinal Neurosurgery

Call Directions Website

Dr. Todd Lanman is widely regarded as one of the world’s foremost spine surgeons and Artificial Disc Replacement innovators.

10/30/2026

A little Halloween fun with Dr. Lanman and his office superheroes! 🦸‍♀️🎃

Blair, Sara, Andrea and Nicole bring their superpowers to the practice every day—today, they just added capes!

Happy Halloween from Dr. Lanman and the team!

Superhero not pictured: Arlene! 🦸‍♀️

10/09/2026

Not every patient who is told they need a spinal fusion has explored every option.

Artificial disc replacement is designed to treat a damaged cervical disc while preserving motion at the treated level. For appropriately selected patients, it may offer an alternative to permanently fusing the vertebrae.

But determining candidacy can be nuanced. Anatomy, the condition of the facet joints, spinal alignment, instability, the number of levels involved, and other clinical factors all play a role—as does a surgeon’s experience evaluating and performing artificial disc replacement.

Dr. Todd Lanman frequently evaluates patients seeking another opinion after being told they are not candidates for ADR. In some cases, a more specialized evaluation reveals that motion preservation may still be an option.

If fusion has been recommended, seeking a second opinion from a surgeon with extensive experience in artificial disc replacement can help ensure you understand the full range of treatment options available to you.

Learn more about cervical artificial disc replacement: https://www.adrspine.com/treatments/cervical-disc-replacement

10/07/2026

When should spinal fusion be considered—and when might another approach better serve the patient?

In a new Becker’s Spine Review feature, Dr. Todd Lanman shares where fusion may be recommended too quickly, including select patients with lumbar stenosis, younger patients who may qualify for artificial disc replacement, and patients with persistent pain after prior surgery.

His perspective emphasizes a principle central to individualized spine care: identify the source of symptoms, evaluate the alternatives, and use fusion when it is truly needed.

Read “Where spine surgeons draw the line on fusion”: https://www.beckersspine.com/spine/where-spine-surgeons-draw-the-line-on-fusion/

10/05/2026

Can you have an artificial disc replacement next to a prior fusion? According to Dr. Todd Lanman, absolutely—and for appropriately selected patients, it can offer an important motion-preserving option.

The disc adjacent to a spinal fusion can experience increased stress and may degenerate over time. Rather than extending the fusion when an adjacent level requires treatment, artificial disc replacement may allow surgeons to address the affected level while preserving motion.

The PCM artificial disc was the first approved for use adjacent to a prior cervical fusion. Dr. Lanman has also served on the clinical trial team for the Synergy Disc, a next-generation cervical artificial disc recently approved by the FDA, and discusses its potential future application in fusion-adjacent cases.

In this video, Dr. Lanman explains why artificial disc replacement next to a fusion can be an important consideration—and how motion preservation continues to expand the options available to appropriately selected patients.

09/18/2026

What if we could better understand which spinal discs are actually contributing to a patient’s low back pain?

I’m participating alongside Dr. Joel Beckett as an investigator in the CLARITY Trial, an FDA clinical research study evaluating NOCISCAN®—an MRS-based software tool designed to provide additional information about the chemical composition of discs in the lumbar spine.

For patients with chronic disc-related low back pain, identifying exactly which disc—or discs—may be contributing to pain can be challenging. Traditional MRI provides important anatomical information, but NOCISCAN® is being studied to determine whether adding metabolic information may help surgeons more accurately identify painful discs and better plan treatment.

Dr. Beckett and I are pleased to participate in research evaluating new technologies that may advance how we diagnose and treat discogenic low back pain.

Adults ages 18–70 with chronic disc-related low back pain who are already planning lumbar spine surgery may be eligible to participate.

Learn more about the CLARITY Trial and eligibility requirements through the link in our bio.

Participation is voluntary and eligibility criteria apply. NOCISCAN® is being evaluated as part of an ongoing clinical research study and is not approved by the U.S. Food and Drug Administration (FDA) to diagnose painful discs or determine surgical treatment.

09/12/2026

What happens when the treatment a patient needs doesn’t fit neatly within the limitations of conventional medicine?

This case of Flat Neck Syndrome highlights an important conversation we need to be having in spine surgery.

Medicine cannot always be one-size-fits-all. Some of the most complex patients require us to think beyond traditional treatment pathways and consider carefully selected, evidence-informed off-label approaches when clinically appropriate.

“Off-label” does not mean experimental or unsafe. It means a treatment or device is being used outside of its specific FDA-approved labeling based on a physician’s clinical judgment, the individual patient’s pathology and an informed discussion of risks, benefits and alternatives.

This is central to what I call Restorative Motion Surgery—looking beyond simply decompressing or stabilizing the spine and asking whether we can restore alignment, preserve motion and reconstruct more natural biomechanics.

For the right patient, that distinction can be life-changing.

In this case study, I explain the pathology, the limitations of conventional treatment options and why an individualized motion-preserving approach was considered.

We should never treat an X-ray or an insurance policy. We treat the individual patient in front of us.

— Todd H. Lanman, MD

08/24/2026

The clinical evidence supporting artificial disc replacement continues to grow. Decades of published research reinforce what Dr. Lanman has long advocated: for appropriately selected patients, motion preservation is a proven alternative to spinal fusion that can preserve function while delivering excellent long-term outcomes.

08/19/2026

Internationally recognized spinal neurosurgeon Dr. Todd H. Lanman shares his experience undergoing his 12th spine surgery—including his eighth lumbar procedure—on July 30, 2026.

The surgery was performed by board-certified spinal neurosurgeons Dr. Joel S. Beckett and Dr. Luke Macyszyn to relieve nerve compression caused by lumbar spinal stenosis at L2–L3 and L3–L4 and to remove selected pelvic fixation hardware associated with persistent symptoms.

Dr. Lanman returned to seeing patients the following Monday and resumed operating just five days after the procedure, requiring only Advil for postoperative pain control. His experience offers a unique surgeon-as-patient perspective on careful diagnosis, trust, recovery, and the ongoing evolution of motion-preserving spine care.

Full article: https://www.spine.md/insights/press/dr-todd-lanman-returns-surgery-five-days-12th-spine-procedure/

08/17/2026

The future of spine surgery is motion preservation.

The FDA approval of the BAGUERA® C Cervical Disc for one- and two-level cervical disc replacement represents another important step forward for patients and surgeons seeking alternatives to fusion.

With nearly two decades of international clinical experience, BAGUERA C adds another well-studied option to the growing field of cervical arthroplasty. What makes this disc particularly interesting is its guided mobile core, designed to allow six degrees of movement while supporting more natural biomechanics and limiting excessive stress on the facet joints.

As implant technology and clinical evidence continue to advance, we are moving closer to a future in which preserving motion—and restoring more natural spinal function—becomes the standard whenever patient anatomy and diagnosis allow.

I’ve dedicated my career to advancing artificial disc replacement, and it is gratifying to see the field continue to evolve with new technologies that expand our ability to personalize care and improve long-term outcomes.

Congratulations to the Spineart team on this important milestone.

08/13/2026

Discogenic low back pain occurs when one or more spinal discs become a source of chronic pain.

While MRI imaging can reveal disc degeneration, determining which disc is actually responsible for a patient's symptoms can be challenging.

Researchers continue to study new technologies that may help improve this process.

Dr. Todd Lanman and Dr. Joel Beckett are participating in the CLARITY Trial, a clinical research study evaluating whether NOCISCAN® can help improve surgical outcomes for patients with discogenic low back pain.

Learn more about the study and eligibility requirements through the link below.

Participation is voluntary and eligibility criteria apply. NOCISCAN® is being evaluated as part of an ongoing clinical research study and is not approved by the U.S. Food and Drug Administration (FDA) to diagnose painful discs or determine surgical treatment.

https://www.spine.md/insights/press/clarity-trial-disc-related-low-back-pain/

Address

450 N. Roxbury Drive 3rd Floor
Beverly Hills, CA
90210

Opening Hours

Monday	8:30am - 4pm
Tuesday	8:30am - 4pm
Wednesday	8:30am - 4pm
Thursday	8:30am - 4pm
Friday	8:30am - 4pm

Telephone

+13103857766

Website

http://www.spine.md/

Alerts

Be the first to know and let us send you an email when Dr. Todd Lanman - Lanman Spinal Neurosurgery posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.